CytoSorbents (STU:HQE1) Ending Cash Position : €9.29 Mil (As of Mar. 2024)

View and export this data going back to 2011. Start your Free Trial

What is CytoSorbents Ending Cash Position?

CytoSorbents's Ending Cash Position for the quarter that ended in Mar. 2024 was €9.29 Mil.

CytoSorbents's quarterly Ending Cash Position increased from Sep. 2023 (€9.41 Mil) to Dec. 2023 (€14.32 Mil) but then declined from Dec. 2023 (€14.32 Mil) to Mar. 2024 (€9.29 Mil).

CytoSorbents's annual Ending Cash Position declined from Dec. 2021 (€47.64 Mil) to Dec. 2022 (€22.50 Mil) and declined from Dec. 2022 (€22.50 Mil) to Dec. 2023 (€14.32 Mil).

CytoSorbents Ending Cash Position Historical Data

The historical data trend for CytoSorbents's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CytoSorbents Ending Cash Position Chart

CytoSorbents Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

11.01

58.71

47.64

22.50

14.32

CytoSorbents Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															19.37	13.70	9.41	14.32	9.29

CytoSorbents Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

CytoSorbents's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	21.854	+	-7.535
	=	14.32

CytoSorbents's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	14.366	+	-5.081
	=	9.29

CytoSorbents Ending Cash Position Related Terms

Thank you for viewing the detailed overview of CytoSorbents's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

CytoSorbents (STU:HQE1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CytoSorbents Corp (STU:HQE1) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

CTSO:USA

Address

305 College Road East, Princeton, NJ, USA, 08540

Website

https://www.cytosorbents.com

CytoSorbents Corp is involves in the treatment of life-threatening conditions in the intensive care (ICU) and cardiac surgery using blood purification via proprietary polymer adsorption technology. It has a number of products commercialized and in development based on this technology platform.

CytoSorbents (STU:HQE1) Headlines

No Headlines